About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

PhoenixBio Co.,Ltd.(6190) Summary

6190
TSE Growth
PhoenixBio Co.,Ltd.
324
JPY
-6
(-1.82%)
Jan 6, 3:14 pm JST
2.05
USD
Jan 6, 1:14 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
0.79
Yield
ー%
Margin Trading Ratio
Stock Price
Jan 6, 2025
Opening Jan 6, 9:00 am
330 JPY 2.09 USD
Previous Close Dec 30
330 JPY 2.08 USD
High Jan 6, 9:53 am
333 JPY 2.11 USD
Low Jan 6, 1:04 pm
324 JPY 2.05 USD
Volume
7,700
Trading Value
3.00M JPY 0.02M USD
VWAP
328.81 JPY 2.08 USD
Minimum Trading Value
32,400 JPY 205 USD
Market Cap
1.31B JPY 8.37M USD
Number of Trades
32
Liquidity & Number of Trades
As of Jan 6, 2025
Liquidity
Slightly Low
1-Year Average
40
1-Year High Nov 22, 2024
1,176
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 27, 2024 0 255,000
Dec 20, 2024 0 244,500
Dec 13, 2024 0 267,200
Dec 6, 2024 0 264,200
Nov 29, 2024 0 271,800
Company Profile
PhoenixBio Co., Ltd. is a biotech venture originating from Hiroshima University, specializing in the production of PXB mice with high human hepatocyte replacement rates and contract testing services.
Sector
Services
PhoenixBio, a biotech venture spun off from Hiroshima University, primarily focuses on providing contract testing services for drug development using PXB mice. PXB mice are chimeric mice with livers largely replaced by human hepatocytes, used for predicting human metabolism and researching hepatitis viruses. The company's main services include pharmacokinetic studies, safety tests, and efficacy evaluations for hepatitis drugs. Additionally, PhoenixBio sells fresh human hepatocytes (PXB-cells) obtained from PXB mice. These services play a crucial role in the preclinical stages of new drug development, supporting pharmaceutical companies in their drug discovery research.